CELLCEUTIX, Inc. (NASDAQOTH:CTIX)

CAPS Rating: 1 out of 5

Results 1 - 6 of 6

Recs

0
Member Avatar EvanBuck (99.90) Submitted: 8/6/2015 7:08:07 PM : Underperform Start Price: $2.96 CTIX Score: +28.08

Another fraud company. http://seekingalpha.com/article/3406365-cellceutix-empty-office-unviable-science-misleading-disclosures-96-percent-downside

Recs

0
Member Avatar BooDog2 (< 20) Submitted: 5/6/2015 1:18:45 PM : Outperform Start Price: $2.42 CTIX Score: -12.91

$CTIX Setting up as a bounce play from long term support. Pending up list to NASDAQ CM. Quite the pipeline with expansion already planned for Kevetrin. Do your DD.

Recs

0
Member Avatar eyezie1 (< 20) Submitted: 4/9/2014 2:47:04 AM : Outperform Start Price: $1.57 CTIX Score: +20.00

Brilacidin is a competitor of Cubist and Durata for use in gram positive infections. FDA is fast tracking antibiotics.

Recs

0
Member Avatar adi101 (85.86) Submitted: 3/2/2014 7:45:11 AM : Outperform Start Price: $1.95 CTIX Score: -5.16

clinical stage, 3 drugs in development: new antibiotic, anti psoriasis, cancer drug.

Recs

0
Member Avatar kmac28 (< 20) Submitted: 12/9/2013 6:49:02 AM : Outperform Start Price: $1.62 CTIX Score: +13.68

Fully dependent on current FDA trials at Dana Farber Cancer institute in MA.

Recs

0
Member Avatar jed71 (99.33) Submitted: 9/12/2013 11:38:55 AM : Underperform Start Price: $1.97 CTIX Score: +16.05

Pump N Dump scam.

Results 1 - 6 of 6

Featured Broker Partners


Advertisement